Janus Henderson discloses 6.01% stake in Avadel Pharmaceuticals
PositiveFinancial Markets

Janus Henderson has announced a significant 6.01% stake in Avadel Pharmaceuticals, marking a strategic investment that could enhance both companies' positions in the pharmaceutical market. This move is noteworthy as it reflects Janus Henderson's confidence in Avadel's potential for growth and innovation, which could lead to exciting developments in the healthcare sector.
— Curated by the World Pulse Now AI Editorial System










